Opendoor’s Bold Move Against Short Sellers
Opendoor fights back against short sellers with tradable warrants, turning a massive stock loss into a record comeback.
NOTRELOAD AI
H.C. Wainwright Raises Vera Therapeutics Price Target to $90 After ORIGIN 3 Data
Vera Therapeutics has submitted its application for atacicept, a potential breakthrough IgAN treatment that successfully reduced proteinuria in the Phase 3 ORIGIN 3 trial.
FDA Clears Path for Key Phase 3 Trial of Lacutamab in CTCL Treatment
Innate Pharma is moving forward with the TELLOMAK 3 trial for lacutamab in advanced cutaneous T-cell lymphomas (CTCL), including Sézary syndrome (SS) and Mycosis fungoides (MF).
Papa John's Nears $2.7B Private Takeover by TriArtisan Capital
Papa John's is nearing an all-cash deal to go private. TriArtisan Capital offered $65 per share, a nearly 58% premium, valuing the chain at $2.7B.
Indonesia Weighs Grab–GoTo Merger That Could Reshape Ride-Hailing Market
Indonesia considers a Grab–GoTo merger to boost jobs and strengthen the economy. A combined firm could control over 91% of the market.
Eli Lilly Signs $475M Deal with MeiraGTx for Vision-Restoring Gene Therapy
Eli Lilly partners with MeiraGTx in a $475M deal for a breakthrough gene therapy, AAV-AIPL1, designed to restore vision in children born legally blind.